All In Biotech

Drug Trial Radar · NCT02810704

Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement

Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement: Balancing Safety and Effectiveness

Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 18,883 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

18,883

Actual

Start

Dec 2016

Primary completion

Sep 2025

Study completion Sep 2025

Sponsor

Lead sponsor
Dartmouth-Hitchcock Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Patient-Centered Outcomes Research Institute; University of Maryland, Baltimore; Brigham and Women's Hospital; Northwestern University; Medical University of South Carolina
First posted
Jun 23, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Supportive care
FDA-regulated drug
No
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

PEPPER is a randomized study comparing the three most commonly used anticoagulants in North America in patients who have elected to undergo primary or revision hip or knee joint replacement surgery. The anticoagulants being compared are enteric coated aspirin, low intensity warfarin, and rivaroxaban.

Conditions

  • Pulmonary Embolism
  • Venous Thrombosis

Interventions

  • Enteric Coated AspirinDrug

  • WarfarinDrug

  • RivaroxabanDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Aggregate primary clinical endpoints of all-cause mortality plus PE and DVTTime frame: Within 6 months of operation
  2. The frequency and nature of bleeding complicationsTime frame: Within 6 months of operation
  3. Specific Joint FunctionTime frame: Within 6 months of operation
  4. Patient Well- BeingTime frame: Within 6 months of operation

Locations

32 sites in 2 countries. Site status is shown where the registry gives one.

  • Mayo Clinic

    Scottsdale, Arizona

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • UCLA

    Los Angeles, California

  • Stanford University Hospital

    Stanford, California

  • Arthritis Surgery Research Foundation

    South Miami, Florida

  • Rush University Medical Center

    Chicago, Illinois

  • Indiana University

    Indianapolis, Indiana

  • Sinai Hospital

    Baltimore, Maryland

  • Johns Hopkins University

    Baltimore, Maryland

  • Brigham & Women's Hospital

    Boston, Massachusetts

  • Boston University Medical Center

    Boston, Massachusetts

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts

  • Lahey Clinic

    Burlington, Massachusetts

  • Mayo Clinic

    Rochester, Minnesota

  • University of Nebraska Medical Center

    Omaha, Nebraska

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire

  • New York University

    New York, New York

  • Northwell Health

    New York, New York

  • Duke University Medical Center

    Durham, North Carolina

  • Cleveland Clinic

    Cleveland, Ohio

  • Penn State Hershey Med Center

    Hershey, Pennsylvania

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Lifespan Health

    East Providence, Rhode Island

  • Medical University of South Carolina

    Charleston, South Carolina

  • University of Utah

    Salt Lake City, Utah

  • Anderson Orthopaedic Institute (VA)

    Alexandria, Virginia

  • University of Virginia

    Charlottesville, Virginia

  • Virginia Commonwealth University Medical Center

    Richmond, Virginia

  • University of Washington

    Seattle, Washington

  • West Virginia University

    Morgantown, West Virginia

  • London Health Sciences Centre

    London, Ontario, Canada

  • University of Ottawa

    Ottawa, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.